within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01C_BetaLactamAntibacterialsPenicillins.J01CR05_PiperacillinAndBetaLactamaseInhibitor;
model PiperacillinAndBetaLactamaseInhibitor 
   extends Pharmacolibrary.Drugs.ATC.J.J01CR05;

  annotation(Documentation(
    info ="<html><body><p>Piperacillin is a broad-spectrum injectable penicillin-class antibiotic, usually co-administered with tazobactam, a beta-lactamase inhibitor. The combination is used for the treatment of moderate to severe bacterial infections including intra-abdominal, skin, gynecological, and nosocomial respiratory tract infections caused by susceptible organisms. This combination is approved and widely used today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for piperacillin/tazobactam in healthy adult volunteers (mostly male and female, mean age ~29-35 years) after single intravenous dose.</p><h4>References</h4><ol><li><p>Dulhunty, JM, et al., &amp; Lipman, J (2024). Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial. <i>JAMA</i> 332(8) 629–637. DOI:<a href=&quot;https://doi.org/10.1001/jama.2024.9779&quot;>10.1001/jama.2024.9779</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38864155/&quot;>https://pubmed.ncbi.nlm.nih.gov/38864155</a></p></li><li><p>Lee, YR, &amp; Baker, NT (2018). Meropenem-vaborbactam: a carbapenem and beta-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae. <i>European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology</i> 37(8) 1411–1419. DOI:<a href=&quot;https://doi.org/10.1007/s10096-018-3260-4&quot;>10.1007/s10096-018-3260-4</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29675787/&quot;>https://pubmed.ncbi.nlm.nih.gov/29675787</a></p></li><li><p>Maneerot, T, et al., &amp; Pattharachayakul, S (2025). Pharmacokinetics of intravenous piperacillin/tazobactam among patients with peritoneal dialysis-associated peritonitis. <i>Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis</i> 45(1) 57–61. DOI:<a href=&quot;https://doi.org/10.1177/08968608241241449&quot;>10.1177/08968608241241449</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38666694/&quot;>https://pubmed.ncbi.nlm.nih.gov/38666694</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end PiperacillinAndBetaLactamaseInhibitor;
